Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice.
about
The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversityTumor necrosis factor α-converting enzyme inhibition reverses hepatic steatosis and improves insulin sensitivity markers and surgical outcome in miceLiver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance.A disintegrin and metalloenzyme (ADAM) 17 activation is regulated by α5β1 integrin in kidney mesangial cells.Palmitate-induced down-regulation of sortilin and impaired GLUT4 trafficking in C2C12 myotubes.Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone densitySexually dimorphic diet-induced insulin resistance in obese tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice.Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes.Macrophage recruitment in obese adipose tissueDecreased IRS2 and TIMP3 expression in monocytes from offspring of type 2 diabetic patients is correlated with insulin resistance and increased intima-media thickness.4-Hydroxyisoleucine ameliorates an insulin resistant-like state in 3T3-L1 adipocytes by regulating TACE/TIMP3 expression.ADAM28 is elevated in humans with the metabolic syndrome and is a novel sheddase of human tumour necrosis factor-α.Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice.ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice.Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma.Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs.Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism.ACSL3 and GSK-3β are essential for lipid upregulation induced by endoplasmic reticulum stress in liver cells.Insulin immuno-neutralization in fed chickens: effects on liver and muscle transcriptome.TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice.Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus.Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model.Transaminase levels in the upper normal range are associated with oral hypoglycemic drug therapy failure in patients with type 2 diabetes.The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.The Antiatherogenic Effect of Fish Oil in Male Mice Is Associated with a Diminished Release of Endothelial ADAM17 and ADAM10 Substrates.
P2860
Q33786342-77931A68-FE2A-48F8-9356-8E5AFDF0151BQ34043373-90593137-8982-4E12-AF05-0F5592C1B44CQ34168368-766C92E7-922E-455C-A9ED-121EAA0B2ABCQ34193829-F778DB51-056B-4ABF-9F59-917D0FD00C38Q34251073-E1650202-3520-4DAC-BCF1-EDC5EC402701Q34510930-07843F90-C724-4251-A1D8-5E1C3035F526Q34696866-8EA8634F-E804-48FD-ADB6-56BA48C98243Q34797602-8FC2FEE7-B503-4837-868F-FB01D6D2DDD5Q35007836-7FA2C9F0-5CB0-4652-A121-ECA373DAEB7DQ35561058-53B4CD01-97BE-4FFC-BF63-6A715221CB10Q36208394-04F57654-B84B-4ECF-A80D-AA9CBF1E364AQ37335291-DE967984-60E1-4801-9211-73ED938872E0Q37629192-3C6B935A-B9CF-4310-A47E-14A3D8277062Q37654401-20563289-2094-4918-ABF7-585C67CCFFE6Q38656435-3A09C006-D24A-4191-B46E-B7704B044081Q39135585-96ABC286-1905-49CB-9D5D-083AB06AC5CFQ39252001-80A13509-809F-4C01-A4D7-77B870A3124CQ39590577-14817B4D-2EF2-453C-89BC-5CDD56A93D8EQ39668185-C562ED7E-58DD-49D1-B3DD-A1017E0FFF2AQ40666812-71A4907D-B501-4D07-9219-978D32266E70Q41219178-5A0ACDDD-80C3-4B0B-BE65-EF5A3A5879C3Q45970750-9D283BBE-AC32-49B9-BF70-DBE983F91364Q47195879-5EF57CFB-B047-48C6-8BB3-E35F47BD494EQ51158595-6AB09067-2E9E-42BE-99AB-99C058ED7D1CQ52873745-DED1C03E-CF5D-4EE6-BD67-8FB7BA547E7FQ53522090-C8F5FD40-7193-4E91-83D4-FC3F975C60AE
P2860
Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Increased tumor necrosis facto ...... e and hepatosteatosis in mice.
@en
Increased tumor necrosis facto ...... e and hepatosteatosis in mice.
@nl
type
label
Increased tumor necrosis facto ...... e and hepatosteatosis in mice.
@en
Increased tumor necrosis facto ...... e and hepatosteatosis in mice.
@nl
prefLabel
Increased tumor necrosis facto ...... e and hepatosteatosis in mice.
@en
Increased tumor necrosis facto ...... e and hepatosteatosis in mice.
@nl
P2093
P2860
P50
P356
P1433
P1476
Increased tumor necrosis facto ...... ce and hepatosteatosis in mice
@en
P2093
Alessia Vivanti
Andrea Urbani
Loredana Fiorentino
Marta Fabrizi
Michele Cavalera
Renato Lauro
P2860
P304
P356
10.1002/HEP.23250
P407
P50
P577
2010-01-01T00:00:00Z